Vertex Pharmaceuticals, Inc. (VRTX) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/05/24
Vertex Pharmaceuticals: Is The Recent Barclays Downgrade Justified? I'm Not ConvincedSeeking Alpha • 09/05/24
Jupiter Endovascular Receives FDA Approval for U.S. Pivotal Study of Vertex Pulmonary Embolectomy System Using Endoportal ControlBusiness Wire • 08/29/24
Prediction: These 4 Future Technologies Will Be Millionaire-Makers -- and Here Are the Top Stocks to Buy Now to Profit From ThemThe Motley Fool • 08/15/24
Vertex Announces CASGEVY™ Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in EnglandBusiness Wire • 08/07/24
Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From NowThe Motley Fool • 08/03/24
Vertex Pharmaceuticals Lifts Annual Guidance, Positive Growth For Its Cystic Fibrosis Franchise And Pain Management PipelineBenzinga • 08/02/24